Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data
06 juil. 2016 04h05 HE
|
Oculus Innovative Sciences, Inc.
May 2016: Highest Monthly Prescriptions Filled in Oculus’ History Quarter Ended March 31, 2016: Highest Quarterly Number of Prescriptions 34% over prior December quarter25% average “quarter over...
Oculus Innovative Sciences Announces Reverse Split of Common Stock
22 juin 2016 05h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets unique and...
Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016
16 juin 2016 16h05 HE
|
Oculus Innovative Sciences, Inc.
Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S. Dermatology Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Oculus...
Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call
02 juin 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth...
Oculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United States
03 mai 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City
28 avr. 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas
27 avr. 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn™ for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
20 avr. 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
Oculus Innovative Sciences Receives European Approval to Market Sinudox™ Indicated for Use in Nasal Irrigation
13 avr. 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 13, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of New Patents for Microcyn® Technology
06 avr. 2016 04h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 06, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the...